Diagnosis of liver pathology through assessment of protein glycosylation
View Patent ↗Methods for diagnosing pathology of the liver in a subject suspected of having such pathology are disclosed. The methods comprise quantifiably detecting glycosylation, and more specifically fucosylation, on proteins in biological fluids, and comparing the detected glycosylation with reference values for the glycosylation of such proteins in healthy or disease states.
1. A method for diagnosing cirrhosis in a subject suspected of having cirrhosis comprising:
obtaining biological fluid from the subject;
contacting a protein from said biological fluid with a fucose-binding lectin, wherein said protein is IgG immunoglobulin, and allowing said lectin to bind to said protein;
quantifiably detecting bound lectin in the biological fluid to obtain a detected bound lectin value; and
comparing the detected bound lectin value with a reference value for lectin binding on said protein in a comparable biological fluid of subjects without cirrhosis, said detected bound lectin value relative to the reference value being indicative of the presence or absence of the cirrhosis, wherein a detected bound lectin value that is less than two-fold higher than said reference value is indicative of the absence of cirrhosis.
2. The method of claim 1 wherein the biological fluid is whole blood, serum, urine, saliva, tears, or mucous.
3. The method of claim 1 , further comprising separating said protein from the biological fluid prior to quantifiably detecting the lectin binding.
4. The method of claim 3 , wherein said protein is separated from the biological fluid with lectins, antibodies, or polypeptides by carbohydrate-recognition domains.
5. The method according to claim 1 wherein a detected bound lectin value that is greater than two-fold higher than said reference value is indicative of the presence of cirrhosis.